Mr. Alan Simpson reports

PHARMACORP CLOSES PREVIOUSLY ANNOUNCED EIGHT-STORE ACQUISITION AND PROVIDES ACQUISITION PIPELINE UPDATE

Further to the April 30, 2026, news release, Pharmacorp Rx Inc. has completed the acquisition of all of the shares of eight Pharmachoice Canada-bannered pharmacies located in Eastern Canada from two arm's-length vendor groups.

The acquisitions significantly expand Pharmacorp's presence in Eastern Canada and increase the corporation's operating footprint to 14 pharmacies across Canada, up from six. Together with two previously announced acquisitions under definitive share purchase agreements, one located in Ontario and one in Western Canada, which are expected to close in late July, 2026, the corporation's store count would increase to 16 pharmacies.

Pharmacorp financed the purchase price for the acquisitions using existing cash resources and credit facilities. Six of the eight locations are situated within a 15-kilometre radius of a primary urban centre, supporting increased market density, operational efficiencies and procurement leverage. The remaining two locations serve rural communities, further diversifying the corporation's regional footprint.

"This acquisition represents a meaningful advancement in Pharmacorp's development of a national network of community pharmacies," said Alan Simpson, executive chairman of Pharmacorp. "It reflects execution at a larger scale while remaining within the valuation discipline, transaction structure and operating parameters that underpin our acquisition platform."

All locations will continue to be operated by their existing managing pharmacists, ensuring continuity of care, preserving patient relationships, and supporting a seamless transition and integration into the Pharmacorp platform.

Acquisition pipeline update

In addition to the closing of the acquisitions, the corporation is pleased to announce that it has entered into two non-binding letters of intent with arm's-length vendors in respect of two additional acquisitions located in Western Canada. The first proposed LOI acquisition is pursuant to an LOI dated June 23, 2026, to acquire all of the issued and outstanding shares of an entity that owns and operates a Remedy'sRx-bannered pharmacy in Western Canada. Pharmacorp intends to continue operating the pharmacy at its existing location and existing Remedy'sRx banner. The second is an asset purchase transaction pursuant an LOI dated June 29, 2026, to acquire the prescription files, patient records and related operational data of an IDA-bannered pharmacy located near an existing Pharmacorp Pharmachoice Canada-bannered pharmacy in Western Canada, with the files expected to be transferred to and serviced by Pharmacorp's nearby pharmacy.

Following the conversion of two previously announced letters of intent into definitive agreements and the signing of these two additional LOIs, the corporation currently has four active non-binding letter of intent progressing through due diligence: two Pharmachoice-bannered pharmacy acquisition opportunities, one IDA-bannered prescription-file purchase opportunity and one Remedy'sRx-bannered pharmacy acquisition opportunity.

The corporation expects to finance the proposed LOI acquisitions using existing cash resources and credit facilities. Completion of each of the proposed LOI acquisitions is subject to the execution of a definitive agreement, which will include the final agreed upon terms and conditions of each proposed LOI acquisition, including such terms, representations, warranties, indemnities and covenants as are customary in transactions similar to the proposed LOI acquisitions, and the satisfaction of customary conditions, including satisfactory due diligence. No finders' fees are payable in respect of the proposed LOI acquisitions. There can be no assurance that the proposed LOI acquisitions will be completed as proposed, or at all.

About Pharmacorp Rx Inc.

Pharmacorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. Through a combination of capital, strategic support and operational expertise, Pharmacorp is building a national network of community pharmacies under the Pharmachoice Canada banner. Following completion of the acquisitions, Pharmacorp will operate 14 Pharmachoice Canada-bannered pharmacies and will continue to acquire both Pharmachoice Canada-bannered and independent pharmacies across Canada, rebranding non-bannered locations under the Pharmachoice Canada platform in accordance with its strategic alliance with Pharmachoice Canada. Pharmacorp shares trade on the TSX Venture Exchange under the symbol PCRX.

We seek Safe Harbor.